论文部分内容阅读
为了控制糖尿病视网膜病变的发生和发展，探讨糖化血红蛋白（ＨｂＡ１Ｃ）与糖尿病视网膜病变的关系，对２１６例糖尿病患者进行了８年跟踪观察，将２１６例糖尿病患者ＨｂＡ１Ｃ８年间平均值进行统计学处理，以分析ＨｂＡ１Ｃ与视网膜病变发生、发展的关系。结果：８年间糖化血红蛋白平均值在６．０％以下者，视网膜病变进展率为０％；ＨｂＡ１Ｃ平均值在６．０％～６．９％之间者，视网膜病变进展率为１３．３％；ＨｂＡ１Ｃ平均值在７．０％～７．９％之间者，视网膜病变进展率为１３．５％；ＨｂＡ１Ｃ平均值在８．０％～８．９％之间者，视网膜病变进展率为４３．４％；ＨｂＡ１Ｃ平均值在９．０％以上者，视网膜病变进展率为４２．０％。因此将糖化血红蛋白控制在６．０％以下，对预防糖尿病视网膜病变的发生、发展极为重要。
In order to control the occurrence and development of diabetic retinopathy, the relationship between HbA1C and diabetic retinopathy was investigated. 216 patients with diabetes were followed up for 8 years. The HbA1C8 level in 216 diabetic patients was measured by Analysis of the relationship between HbA1C and the occurrence and development of retinopathy. Results: The average rate of HbA1C was 6.0% -6.3%, the rate of retinopathy was 13.3%, the average rate of HbA1C was 6.0% ; HbA1C average between 7.0% and 7.9%, retinopathy progression rate was 13.5%; HbA1C average between 8.0% and 8.9%, the progress rate of retinopathy was 43.4%. The average rate of HbA1C was 9.0%, and the rate of retinopathy was 42.0%. Therefore, the control of glycosylated hemoglobin below 6.0%, to prevent the occurrence and development of diabetic retinopathy is extremely important.